What “Lidoderm generic market size” usually means (and the data that would drive it)
“Lidoderm” is the brand name for a lidocaine 5% patch. When people ask for the “generic market size,” they usually mean one (or more) of these:
- Total U.S. sales of lidocaine 5% patches (brand + generic).
- Sales of the generic version(s) after launch (if generic products are on the market).
- The addressable market for generic entrants going forward.
Answering any of those precisely requires underlying sales data (e.g., IQVIA/PMPRetail/IMS, company filings, or published market reports). The provided information here doesn’t include figures, methodology, or cited sources for U.S. sales of Lidoderm or its generic alternatives, so a specific market-size number can’t be calculated from what’s available.
How to estimate the U.S. generic market size for Lidoderm (practical approach)
If you need a usable estimate, the typical workflow is:
1. Identify the exact product scope: lidocaine 5% patch (usually NDC-level/label-level).
2. Pull U.S. sales for that scope for a recent base year (from a market database or public datasets).
3. Separate brand vs generic using product ownership or data tags.
4. Define the forecast horizon and growth assumptions (total patch market growth, payer mix, patient uptake, competition, and substitution).
To do this correctly, you also need clarity on whether “market size” means units, dollars, or prescriptions.
Key details that can change the number a lot
The market size can swing depending on:
- Whether “market” includes all lidocaine 5% patch NDCs or only the Lidoderm-labeled product.
- Whether you count returns/discounts (net sales) or gross sales.
- Time period (last 12 months vs full year).
- Channel (retail vs total pharmacy vs all settings).
Quick clarifying questions so I can produce the right market-size figure
If you answer these, I can narrow to the correct definition and structure:
1. Do you want U.S. market size in dollars (net sales) or in units/prescriptions?
2. Do you want total lidocaine 5% patch market (brand + generic) or only generic share?
3. What time frame (e.g., 2023 actual, 2024 TTM, or a forecast for 2025–2028)?
Sources
No sources were provided with your question, so I can’t cite a market-size value. If you share a link/table or the dataset you’re using (even just a screenshot of sales totals), I can compute generic market size and generic share from it.